Article Details

Camrelizumab Combo Elicits Encouraging Efficacy in Second-Line Esophageal Squamous Cell ...

Retrieved on: 2021-01-15 18:00:00

Tags for this article:

Click the tags to see associated articles and topics

Camrelizumab Combo Elicits Encouraging Efficacy in Second-Line Esophageal Squamous Cell .... View article details on hiswai:

Excerpt

The only grade 3 or higher immune-related event was RCEP, which occurred in 1 patient (2.2%). Patients received treatment until disease progression ...

Article found on: www.targetedonc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up